Lung Cancer Alliance Applauds Additional Funding for Lung Cancer Research Program

July 5, 2018

SAP Partners

The House of Representatives’ passage of a bipartisan amendment securing an additional $6 million to the Department of Defense Lung Cancer Research Program in the 2019 fiscal year budget brought praise from Lung Cancer Alliance.

The House of Representatives’ passage of a bipartisan amendment securing an additional $6 million to the Department of Defense Lung Cancer Research Program in the 2019 fiscal year budget, brought praise from the Lung Cancer Alliance.

With the additional $6 million, the research funding levels for the program were restored from $14 million to the original $20 million approved in 2009 by Congress for the Congressionally Directed medical Research Programs' (CDMRP's) Lung Cancer Research Program. According to the Lung Cancer Alliance, the move was pushed by Congressman Rick Nolan, D-Minnesota, and Frank LoBiondo, R-New Jersey.

The Lung Cancer Research Program at CDMRP has played a critical role in supporting innovative lung cancer research within the military and general public is several areas, including risk assessment, early detection, and survivorship.

Read more about CDMRP and the Lung Cancer Alliance's full press release here.